CCMH
BMRN icon

Cornerstone Capital Management Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-26,726
Closed -$2.2M – 1390
2016
Q1 		$2.2M Sell
26,726
-3,812
-12% -$310K 0.02% 697
2015
Q4 		$3.2M Sell
30,538
-4,620
-13% -$482K 0.03% 591
2015
Q3 		$3.7M Buy
35,158
+32,538
+1,242% +$4.35M 0.03% 520
2015
Q2 		$358K Buy
+2,620
New +$325K ﹤0.01% 1078
2013
Q4 		– Sell
-1,047
Closed -$75K – 1258
2013
Q3 		$75K Sell
1,047
-17,469
-94% -$1.16M ﹤0.01% 1145
2013
Q2 		$1.03M Buy
+18,516
New +$1.15M 0.01% 797

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return